Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-22

Clinical Trial Update: PRESERFLO® MicroShunt Extension Study

View source ↗

Summary

Completion update for the PRESERFLO MicroShunt extension study in primary open-angle glaucoma with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PreserFlo MicroShunt

Snippet

Sponsor: InnFocus Inc. | Conditions: Primary Open-angle Glaucoma | Status: COMPLETED | Results posted: 2024-03-22